AI That Heals: The Real Work Behind Intelligent Medicine
Join us for a webinar on data, design, and deployment in healthcare AI.
Discover how ethical AI principles can be transformed into real-world innovation. Learn how addressing the Remaining84 challenge leads to safer, fairer, and more clinically relevant AI solutions in oncology.
This webinar explores how PAICON bridges the gap between ethical AI ideals and clinical practice. Participants will gain insights into how data diversity, regulatory compliance, and transparency fuel trustworthy AI models.
Learn how the Remaining84 framework turns fairness into innovation, enabling hospitals, pharma, and AI companies to create impactful, compliant, and equitable cancer AI.
🎁 Participants receive:
The Exclusive Whitepaper: Equity Is Not Optional: The Remaining84 in Practice
About the Speaker:
Dr. Manasi Aichmueller-Ratnaparkhe
Dr. Manasi Aichmüller-Ratnaparkhe, CEO and Co-Founder of PAICON, leads the mission to make cancer diagnostics equitable and globally relevant by turning complex data into inclusive diagnostics.
With a PhD in Cancer Genetics from Heidelberg University and an MBA Essentials from LSE, she bridges research, innovation, and care.
She drives global collaborations and leads Remaining84, the PAICON's initiative aimed at including the 84% of the world’s population that is currently underrepresented in global cancer datasets.
Linkedin: https://www.linkedin.com/in/dr-manasi-a-6286a347/
About the company: PAICON GmbH
Too often, cancer AI works well, just not for everyone.
At PAICON, we're changing that. Most diagnostic algorithms are trained on data that excludes the majority of the world.
Our response: a globally sourced, multimodal cancer data lake representing 60+ countries. By designing AI that reflects real-world diversity, we are moving beyond one-size-fits-all models to build diagnostic tools that deliver for every population. Because we believe that cancer diagnostics should work for everyone, not just selected few.
Winner of the DMEA nova Award 2025, PAICON joins the ranks of the most promising emerging startups in digital health. Awarded annually at DMEA, one of Europe’s leading digital healthcare events, the award recognizes innovation, impact, and forward-thinking ideas that are shaping the future of healthcare. This distinction also provided PAICON with an exclusive opportunity to showcase their pioneering approach and share their vision with the broader startup and digital health community.
Linkedin: https://www.linkedin.com/company/paiconcom/
Website: https://www.paicon.com